VIRMA and neoplasm: Mechanistically, VIRMA upregulated LncRNA EBLN3P expression in an m6A-dependent manner, and EBLN3P competed with miR-153-3p to increase VIRMA expression, thereby reducing ferroptosis in tumor cells and enhancing their radioresistance [75].